Want to see AU:MVF full AI Analyst Report?
MVF Stock Chart & Stats
AU$0.66
AU$0.03(4.58%)
At close: 4:00 PM EDT
AU$0.66
AU$0.03(4.58%)
Day’s Range― - ―
52-Week RangeAU$0.58 - AU$0.90
Previous CloseN/A
Volume457.94K
Average Volume (3M)2.18M
Market Cap
AU$272.74M
Enterprise ValueAU$481.35
Total Cash (Recent Filing)AU$8.14M
Total Debt (Recent Filing)AU$281.81M
Price to Earnings (P/E)18.0
Beta1.30
Next Earnings
Aug 24, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield5.33%
Share Statistics
EPS (TTM)0.04
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.78Price Target Upside18.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$277.19M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 74.5% revenue increase reflects meaningful expansion in patient volumes or service mix, supporting long-term top-line momentum. Durable demand for fertility services and larger treatment throughput provide a base for reinvestment in clinics and labs across 2–6 months and beyond.
Profit MarginsSustained gross and net margins indicate structural pricing power and efficient clinical/laboratory operations. Margin durability supports funding for research, quality staffing and dividends, and provides cushion against cyclical patient volumes over the medium term.
Balance Sheet / LeverageA balanced leverage profile with D/E ~0.73 and a 10.2% ROE suggests prudent capital structure and effective use of equity. This supports capacity to finance clinic expansion or lab upgrades without excessive refinancing risk over the next several quarters.
Bears Say
Free Cash Flow CollapseA near-total decline in free cash flow severely limits internal funding for capex, working capital and dividends. Over 2–6 months this raises reliance on external financing, constraining strategic investments and increasing vulnerability to funding cost swings.
Weak Cash ConversionLow conversion of earnings to cash (0.21) signals working capital pressure, receivable or timing issues that reduce financial flexibility. Persistently weak conversion undermines the sustainability of reported profits and strains liquidity for clinic operations.
Revenue Volatility / Data AmbiguityConflicting growth metrics point to volatility, seasonality, or one-off accounting items that impair forecasting reliability. For investors and management this reduces confidence in trend extrapolation and complicates medium-term capacity planning and resource allocation.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.57 and its highest was AU$0.90 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$272.74M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 24, 2026 which is in 17 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.025 by -AU$0.007.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Annually dividend of AU$0.012 which represents an annual dividend yield of 5.33%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.02.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.018 in its last earnings report, missing expectations of AU$0.025. Following the earnings report the stock price went up 2.954%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.78 (18.18% Upside)
AU$0.78 (18.18% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
5.33%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.78
▲(18.18% Upside)
Technical Analysis
Genetic Technologies
―
Healius Limited
―
Cryosite Limited
―
Sonic Healthcare Limited
―
Australian Clinical Labs Ltd
―